Physicians Formula Stock Price, News & Analysis (NASDAQ:FACE)

$4.90 0.00 (0.00 %)
(As of 03/20/2018 05:55 AM ET)
Previous Close$4.90
Today's RangeN/A
52-Week Range$2.76 - $5.14
Average Volume78,600 shs
Market Capitalization$67.27 million
P/E Ratio35.00
Dividend YieldN/A

About Physicians Formula (NASDAQ:FACE)

Physicians Formula Holdings, Inc. is a United States-based company that manufactures and distributes mass color cosmetics. The Company focuses in color correction and brings department store concepts to the mass market. Its products focus on addressing skin imperfections through a problem-solution approach. Its products address specific, everyday cosmetics needs and include face powders, bronzers, concealers, blushes, foundations, eye shadows, eye liners, brow makeup and mascaras. The Company sells its products in the mass market channel to retailers.

Receive FACE News and Ratings via Email

Sign-up to receive the latest news and ratings for FACE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Personal Products
SectorNon-Cyclical Consumer Goods & Services


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio35
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Physicians Formula (NASDAQ:FACE) Frequently Asked Questions

What is Physicians Formula's stock symbol?

Physicians Formula trades on the NASDAQ under the ticker symbol "FACE."

Who are some of Physicians Formula's key competitors?

Has Physicians Formula been receiving favorable news coverage?

Press coverage about FACE stock has been trending somewhat positive on Tuesday, Accern Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Physicians Formula earned a media sentiment score of 0.06 on Accern's scale. They also assigned news articles about the consumer goods maker an impact score of 45.95 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Physicians Formula?

Shares of FACE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Physicians Formula's stock price today?

One share of FACE stock can currently be purchased for approximately $4.90.

How big of a company is Physicians Formula?

Physicians Formula has a market capitalization of $67.27 million.

How can I contact Physicians Formula?

Physicians Formula's mailing address is 1055 W 8th St, AZUSA, CA 91702-2248, United States. The consumer goods maker can be reached via phone at +1-626-3343395.

MarketBeat Community Rating for Physicians Formula (FACE)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  78
MarketBeat's community ratings are surveys of what our community members think about Physicians Formula and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Physicians Formula (NASDAQ:FACE) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Physicians Formula (NASDAQ:FACE) Earnings History and Estimates Chart

Earnings by Quarter for Physicians Formula (NASDAQ:FACE)

Physicians Formula (NASDAQ FACE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/15/2012Q3 2012($0.10)ViewN/AView Earnings Details
8/14/2012Q2 2012$0.13ViewN/AView Earnings Details
5/3/2012Q1 2012$0.05$0.16ViewN/AView Earnings Details
3/6/2012Q4 2011($0.03)($0.01)ViewN/AView Earnings Details
11/3/2011Q3 2011($0.06)($0.04)ViewN/AView Earnings Details
8/4/2011Q2 2011$0.01($0.02)ViewN/AView Earnings Details
5/5/2011Q1 2011($0.05)$0.03ViewN/AView Earnings Details
3/10/2011Q4 2010($0.05)($0.07)ViewN/AView Earnings Details
11/4/2010Q3 2010($0.04)($0.03)ViewN/AView Earnings Details
8/5/2010Q2 2010$0.01$0.09ViewN/AView Earnings Details
5/6/2010Q1 2010$0.02$0.04ViewN/AView Earnings Details
11/5/2009Q3 2009($0.05)($0.02)ViewN/AView Earnings Details
8/6/2009Q2 2009($0.15)$0.09ViewN/AView Earnings Details
5/11/2009Q1 2009$0.14($0.13)ViewN/AView Earnings Details
3/31/2009Q4 2008$0.12$0.13ViewN/AView Earnings Details
11/3/2008Q3 2008$0.01$0.12ViewN/AView Earnings Details
8/11/2008Q2 2008($0.07)($0.14)ViewN/AView Earnings Details
5/5/2008Q1 2008$0.32$0.34ViewN/AView Earnings Details
3/10/2008Q4 2007$0.27$0.33ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Physicians Formula (NASDAQ:FACE) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Physicians Formula (NASDAQ:FACE)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Physicians Formula (NASDAQ FACE)

No insider trades for this company have been tracked by


Physicians Formula (NASDAQ FACE) News Headlines


SEC Filings

Physicians Formula (NASDAQ:FACE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Physicians Formula (NASDAQ:FACE) Income Statement, Balance Sheet and Cash Flow Statement


Physicians Formula (NASDAQ FACE) Stock Chart for Tuesday, March, 20, 2018

Loading chart…

This page was last updated on 3/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.